81 related articles for article (PubMed ID: 16488535)
1. Bifunctional effect of resveratrol on the expression of ErbB2 in human breast cancer cell.
Choi HK; Yang JW; Kang KW
Cancer Lett; 2006 Oct; 242(2):198-206. PubMed ID: 16488535
[TBL] [Abstract][Full Text] [Related]
2. ErbB2 overexpression in p53-inactivated mammary epithelial cells.
Yang JW; Lee EY; Kang KW
FEBS Lett; 2006 Nov; 580(27):6501-8. PubMed ID: 17101136
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells.
Yang JW; Kim MR; Kim HG; Kim SK; Jeong HG; Kang KW
Arch Pharm Res; 2008 Mar; 31(3):350-6. PubMed ID: 18409049
[TBL] [Abstract][Full Text] [Related]
4. Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
Nolens G; Pignon JC; Koopmansch B; Elmoualij B; Zorzi W; De Pauw E; Winkler R
Breast Cancer Res; 2009; 11(6):R83. PubMed ID: 19906305
[TBL] [Abstract][Full Text] [Related]
5. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T
Cancer Res; 1998 Dec; 58(23):5466-72. PubMed ID: 9850080
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
7. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
St-Laurent V; Sanchez M; Charbonneau C; Tremblay A
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):23-37. PubMed ID: 15862947
[TBL] [Abstract][Full Text] [Related]
8. Induction of ErbB2 by ultraviolet A irradiation: potential role in malignant transformation of keratinocytes.
Han CY; Lim SC; Choi HS; Kang KW
Cancer Sci; 2008 Mar; 99(3):502-9. PubMed ID: 18177484
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells.
Lu R; Serrero G
J Cell Physiol; 1999 Jun; 179(3):297-304. PubMed ID: 10228948
[TBL] [Abstract][Full Text] [Related]
10. Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells.
Delacroix L; Begon D; Chatel G; Jackers P; Winkler R
DNA Cell Biol; 2005 Sep; 24(9):582-94. PubMed ID: 16153159
[TBL] [Abstract][Full Text] [Related]
11. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J
Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186
[TBL] [Abstract][Full Text] [Related]
12. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC
Oncogene; 2000 Jan; 19(4):490-7. PubMed ID: 10698518
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
Wietzke JA; Ward EC; Schneider J; Welsh J
Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
[TBL] [Abstract][Full Text] [Related]
14. Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.
Orso F; Cottone E; Hasleton MD; Ibbitt JC; Sismondi P; Hurst HC; De Bortoli M
Biochem J; 2004 Jan; 377(Pt 2):429-38. PubMed ID: 14565844
[TBL] [Abstract][Full Text] [Related]
15. A positive feedback pathway of estrogen biosynthesis in breast cancer cells is contained by resveratrol.
Wang Y; Ye L; Leung LK
Toxicology; 2008 Jun; 248(2-3):130-5. PubMed ID: 18462857
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
Ma C; Lin H; Leonard SS; Shi X; Ye J; Luo J
Oncogene; 2003 Aug; 22(34):5281-90. PubMed ID: 12917629
[TBL] [Abstract][Full Text] [Related]
17. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
Trost TM; Lausch EU; Fees SA; Schmitt S; Enklaar T; Reutzel D; Brixel LR; Schmidtke P; Maringer M; Schiffer IB; Heimerdinger CK; Hengstler JG; Fritz G; Bockamp EO; Prawitt D; Zabel BU; Spangenberg C
Cancer Res; 2005 Feb; 65(3):840-9. PubMed ID: 15705882
[TBL] [Abstract][Full Text] [Related]
18. Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells.
Serrero G; Lu R
Antioxid Redox Signal; 2001 Dec; 3(6):969-79. PubMed ID: 11813992
[TBL] [Abstract][Full Text] [Related]
19. The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer.
Chu I; Blackwell K; Chen S; Slingerland J
Cancer Res; 2005 Jan; 65(1):18-25. PubMed ID: 15665275
[TBL] [Abstract][Full Text] [Related]
20. AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen.
Perissi V; Menini N; Cottone E; Capello D; Sacco M; Montaldo F; De Bortoli M
Oncogene; 2000 Jan; 19(2):280-8. PubMed ID: 10645007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
